Jennie A Hutton
Overview
Explore the profile of Jennie A Hutton including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
153
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mota F, Yelland T, Hutton J, Parker J, Patsiarika A, Chan A, et al.
Chembiochem
. 2021 Oct;
23(1):e202100463.
PMID: 34647407
Vascular endothelial growth factors (VEGFs) regulate significant pathways in angiogenesis, myocardial and neuronal protection, metabolism, and cancer progression. The VEGF-B growth factor is involved in cell survival, anti-apoptotic and antioxidant...
2.
Bell A, Yu Z, Hutton J, Wright M, Brannigan J, Paape D, et al.
J Med Chem
. 2020 Jun;
63(14):7740-7765.
PMID: 32575985
The leishmaniases, caused by species of protozoan parasites, are neglected tropical diseases with millions of cases worldwide. Current therapeutic approaches are limited by toxicity, resistance, and cost. -Myristoyltransferase (NMT), an...
3.
Lim C, Ha K, Clarke R, Gavin L, Cook D, Hutton J, et al.
Bioorg Med Chem
. 2019 Jul;
27(20):114962.
PMID: 31307763
The global emergence of antibiotic resistance is one of the most serious challenges facing modern medicine. There is an urgent need for validation of new drug targets and the development...
4.
Mousnier A, Bell A, Swieboda D, Morales-Sanfrutos J, Perez-Dorado I, Brannigan J, et al.
Nat Chem
. 2018 May;
10(6):599-606.
PMID: 29760414
Rhinoviruses (RVs) are the pathogens most often responsible for the common cold, and are a frequent cause of exacerbations in asthma, chronic obstructive pulmonary disease and cystic fibrosis. Here we...
5.
Paape D, Bell A, Heal W, Hutton J, Leatherbarrow R, Tate E, et al.
PLoS Negl Trop Dis
. 2014 Dec;
8(12):e3363.
PMID: 25522361
We have refined a medium-throughput assay to screen hit compounds for activity against N-myristoylation in intracellular amastigotes of Leishmania donovani. Using clinically-relevant stages of wild type parasites and an Alamar...
6.
Hutton J, Goncalves V, Brannigan J, Paape D, Wright M, Waugh T, et al.
J Med Chem
. 2014 Sep;
57(20):8664-70.
PMID: 25238611
Inhibitors of Leishmania N-myristoyltransferase (NMT), a potential target for the treatment of leishmaniasis, obtained from a high-throughput screen, were resynthesized to validate activity. Crystal structures bound to Leishmania major NMT...
7.
Brannigan J, Roberts S, Bell A, Hutton J, Hodgkinson M, Tate E, et al.
IUCrJ
. 2014 Jul;
1(Pt 4):250-60.
PMID: 25075346
The leishmaniases are a spectrum of global diseases of poverty associated with immune dysfunction and are the cause of high morbidity. Despite the long history of these diseases, no effective...